Injector,intraosseous

The Defense Logistics Agency Troop Support Medical Supply Chain seeks quotes for one intraosseous injector (NSN 6515-01-571-3152) under RFQ SPE2DS27T1029, with quotes due November 2, 2026, a date that has passed. The Set Aside line reads "No Set-Aside Used," so the procurement is unrestricted, and quotes must be submitted through the DLA Internet Bid Board System (DIBBS) under a Fast Auto Evaluation solicitation.

The attachment places delivery at Fort Bliss, Texas, within 20 days, on FOB Destination terms with inspection at destination. The item must meet a -20 to 50 degrees Celsius temperature range, support 500 insertions, and carry a 120-month shelf life, with no more than 18 months elapsed from manufacture to delivery. It is an FDA-regulated Class II medical device. Compliance requirements include the Berry Amendment, the Buy American Act, domestic material sourcing restrictions, DFARS covered defense telecommunications equipment restrictions, DFARS safeguarding of defense information, MIL-STD-129 marking, hazard warning labels and safety data sheets for any hazardous materials, and MARAD notification if ocean transportation is anticipated. Offerors are encouraged to submit quantity ranges. Award may be automated unless first article testing applies.

The attachment names two sources of supply: Combat Medical Systems LLC (CAGE 515E6, Part Number 35-040) and Teleflex LLC (CAGE 8BXN8, Part Number 9040). Procurement history shows recurring purchases of this NSN at unit costs of approximately $346 to $478, with awards to both named vendors in recent years.